Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Min Liu

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 28, 2020
Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial FibrillationWei-Ru Chiou, Chun-Che Huang, Po-Lin Lin, et al.
Scientific Reports|March 9, 2022
Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillationWei-Ru Chiou, Po-Lin Lin, Chun-Che Huang, et al.
Molecular Biology Reports|May 3, 2024
Syndecan-4 is required for early-stage repair responses during zebrafish heart regenerationZih-Yin Lai, Chung-Chi Yang, Po-Hsun Chen, et al.
Journal of Neuroinflammation|October 26, 2023
Cell-specific NFIA upregulation promotes epileptogenesis by TRPV4-mediated astrocyte reactivityShuo Kong, Tao-Xiang Chen, Xiang-Lei Jia, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 13, 2021
Exploratory Evaluation of Rhythm Control by Dronedarone in Combination With Low-Dose Rivaroxaban, Warfarin, Antiplatelet, or None of the Antithrombotic Therapy in High-Risk Patients With Non-Permanent Atrial Fibrillation: A Retrospective Cohort StudyPo-Lin Lin, Wei-Ru Chiou, Min-I Su, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 24, 2021
Prognostic superiority of global longitudinal strain beyond four-tiered ventricular hypertrophy in asymptomatic individualsKuo-Tzu Sung, Yi-Hsuan Chen, Jen-Yuan Kuo, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 19, 2022
Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4) Mitigates SeizuresMeng-Liu Zeng, Jing-Jing Cheng, Shuo Kong, et al.
Diagnostics (Basel, Switzerland)|September 23, 2020
Aortic Root Remodeling as an Indicator for Diastolic Dysfunction and Normative Ranges in Asians: Comparison and Validation with Multidetector Computed TomographyLawrence Yu-Min Liu, Chun-Ho Yun, Jen-Yuan Kuo, et al.
ACS Applied Materials & Interfaces|January 12, 2022
Enhanced Oral NO Delivery through Bioinorganic Engineering of Acid-Sensitive Prodrug into a Transformer-like DNIC@MOF MicrorodYong-Huei Hong, Manmath Narwane, Lawrence Yu-Min Liu, et al.
ESC Heart Failure|October 28, 2020
Associations of region-specific visceral adiposity with subclinical atrial dysfunction and outcomes of heart failureBo-Han Huang, Shun-Chuan Chang, Chun-Ho Yun, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 28, 2020
Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial FibrillationWei-Ru Chiou, Chun-Che Huang, Po-Lin Lin, et al.
Scientific Reports|March 9, 2022
Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillationWei-Ru Chiou, Po-Lin Lin, Chun-Che Huang, et al.
Molecular Biology Reports|May 3, 2024
Syndecan-4 is required for early-stage repair responses during zebrafish heart regenerationZih-Yin Lai, Chung-Chi Yang, Po-Hsun Chen, et al.
Journal of Neuroinflammation|October 26, 2023
Cell-specific NFIA upregulation promotes epileptogenesis by TRPV4-mediated astrocyte reactivityShuo Kong, Tao-Xiang Chen, Xiang-Lei Jia, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 13, 2021
Exploratory Evaluation of Rhythm Control by Dronedarone in Combination With Low-Dose Rivaroxaban, Warfarin, Antiplatelet, or None of the Antithrombotic Therapy in High-Risk Patients With Non-Permanent Atrial Fibrillation: A Retrospective Cohort StudyPo-Lin Lin, Wei-Ru Chiou, Min-I Su, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 24, 2021
Prognostic superiority of global longitudinal strain beyond four-tiered ventricular hypertrophy in asymptomatic individualsKuo-Tzu Sung, Yi-Hsuan Chen, Jen-Yuan Kuo, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 19, 2022
Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4) Mitigates SeizuresMeng-Liu Zeng, Jing-Jing Cheng, Shuo Kong, et al.
Diagnostics (Basel, Switzerland)|September 23, 2020
Aortic Root Remodeling as an Indicator for Diastolic Dysfunction and Normative Ranges in Asians: Comparison and Validation with Multidetector Computed TomographyLawrence Yu-Min Liu, Chun-Ho Yun, Jen-Yuan Kuo, et al.
ACS Applied Materials & Interfaces|January 12, 2022
Enhanced Oral NO Delivery through Bioinorganic Engineering of Acid-Sensitive Prodrug into a Transformer-like DNIC@MOF MicrorodYong-Huei Hong, Manmath Narwane, Lawrence Yu-Min Liu, et al.
ESC Heart Failure|October 28, 2020
Associations of region-specific visceral adiposity with subclinical atrial dysfunction and outcomes of heart failureBo-Han Huang, Shun-Chuan Chang, Chun-Ho Yun, et al.
Pageof 10